Agustin Melian - Apr 5, 2021 Form 4 Insider Report for Allovir, Inc. (ALVR)

Role
Chief Medical Officer
Signature
/s/ Brett Hagen, as Attorney-in-Fact
Stock symbol
ALVR
Transactions as of
Apr 5, 2021
Transactions value $
-$896,685
Form type
4
Date filed
9/20/2021, 04:05 PM
Next filing
Sep 29, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ALVR Common Stock Sale -$435K -18.2K -3.53% $23.89* 498K Apr 5, 2021 Direct F1
transaction ALVR Common Stock Sale -$372K -18.6K -3.73% $19.99* 480K Jul 2, 2021 Direct F1
transaction ALVR Common Stock Sale -$19.2K -800 -0.17% $24.03* 479K Sep 15, 2021 Direct F2, F3
transaction ALVR Common Stock Sale -$70.8K -2.95K -0.62% $24.01* 476K Sep 17, 2021 Direct F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock, and does not represent a discretionary trade by the reporting person.
F2 This sale was effected pursuant to a Rule 10b5-1 trading plan adopted on December 14, 2020.
F3 The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $24.00 to $24.08. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.